Department of General Surgery, The Fifth Affiliated Hospital of Harbin Medical University, Daqing, 163316, Heilongjiang Province, China.
Eur J Med Res. 2024 Oct 30;29(1):523. doi: 10.1186/s40001-024-02124-8.
Drug-carrying nanoparticles can be recognized and captured by macrophages and cleared away by the immune system, resulting in reduced drug efficacy and representing the main drawbacks. Biomimetic nanoparticles, which are coated with cell membranes from natural resources, have been applied to address this problem. This type of nanoparticle maintains some specific biological activities, allowing them to carry drugs reaching designated tissues effectively and have a longer time in circulation. This review article aims to summarize recent progress on biomimetic nanoparticles based on cell membranes. In this paper, we have introduced the classification of biomimetic nanoparticles, their preparation and characterization, and their applications in inflammatory diseases and malignant tumors. We have also analyzed the shortcomings and prospects of this technology, hoping to provide some clues for basic researchers and clinicians engaged in this field.
载药纳米颗粒可被巨噬细胞识别和吞噬,并被免疫系统清除,导致药物疗效降低,这是其主要缺点。仿生纳米颗粒是利用天然资源的细胞膜进行包被,已经被应用于解决这个问题。这类纳米颗粒保持了一些特定的生物活性,使它们能够有效地携带药物到达指定组织,并在循环中保持更长时间。本文综述了基于细胞膜的仿生纳米颗粒的最新进展。本文介绍了仿生纳米颗粒的分类、制备和表征,以及它们在炎症性疾病和恶性肿瘤中的应用。我们还分析了该技术的缺点和前景,希望为从事该领域的基础研究人员和临床医生提供一些线索。
Drug Des Devel Ther. 2020
Colloids Surf B Biointerfaces. 2022-11
Molecules. 2021-8-20
Drug Deliv Transl Res. 2023-3
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025
Bioact Mater. 2025-7-7
Adv Sci (Weinh). 2025-8
Eur J Med Res. 2025-6-21
Int J Mol Sci. 2025-2-28
Front Cell Dev Biol. 2023-4-19
Bioeng Transl Med. 2022-11-2
Proc Natl Acad Sci U S A. 2023-1-3
Mil Med Res. 2022-10-9
Chem Rev. 2022-7-13
Clin J Am Soc Nephrol. 2022-6
Angew Chem Int Ed Engl. 2022-6-13
Pharmaceuticals (Basel). 2022-1-27